IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BONARDI, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.002
NA - Nord America 10.742
AS - Asia 9.460
SA - Sud America 872
AF - Africa 153
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 6
Totale 34.269
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.528
GB - Regno Unito 3.841
IT - Italia 3.659
SG - Singapore 3.100
CN - Cina 2.919
RU - Federazione Russa 1.098
DE - Germania 932
SE - Svezia 863
HK - Hong Kong 760
IN - India 570
BR - Brasile 565
FR - Francia 558
TR - Turchia 532
UA - Ucraina 507
KR - Corea 467
VN - Vietnam 451
NL - Olanda 356
IE - Irlanda 355
FI - Finlandia 348
EU - Europa 248
CO - Colombia 139
CA - Canada 138
JP - Giappone 119
BD - Bangladesh 115
GR - Grecia 98
PL - Polonia 87
AR - Argentina 78
ID - Indonesia 74
BE - Belgio 52
IR - Iran 46
PK - Pakistan 42
ZA - Sudafrica 42
AT - Austria 40
DK - Danimarca 40
MX - Messico 40
ES - Italia 38
IQ - Iraq 35
CH - Svizzera 33
SA - Arabia Saudita 32
AU - Australia 31
EC - Ecuador 25
TW - Taiwan 23
MY - Malesia 21
UZ - Uzbekistan 20
VE - Venezuela 18
EG - Egitto 17
PT - Portogallo 17
PH - Filippine 16
PE - Perù 15
KE - Kenya 14
IL - Israele 12
JO - Giordania 12
MA - Marocco 12
TH - Thailandia 12
BG - Bulgaria 11
AE - Emirati Arabi Uniti 10
CL - Cile 10
LT - Lituania 10
PY - Paraguay 10
CZ - Repubblica Ceca 9
DZ - Algeria 8
NG - Nigeria 8
AZ - Azerbaigian 7
CM - Camerun 7
JM - Giamaica 7
LU - Lussemburgo 7
OM - Oman 7
TN - Tunisia 7
BO - Bolivia 6
CI - Costa d'Avorio 6
ET - Etiopia 6
GE - Georgia 6
KZ - Kazakistan 6
PS - Palestinian Territory 6
UY - Uruguay 6
AM - Armenia 5
GH - Ghana 5
HU - Ungheria 5
NP - Nepal 5
RO - Romania 5
CR - Costa Rica 4
KH - Cambogia 4
KW - Kuwait 4
LK - Sri Lanka 4
NI - Nicaragua 4
NO - Norvegia 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
SV - El Salvador 4
BY - Bielorussia 3
CY - Cipro 3
GA - Gabon 3
HR - Croazia 3
LB - Libano 3
LV - Lettonia 3
MD - Moldavia 3
MO - Macao, regione amministrativa speciale della Cina 3
PR - Porto Rico 3
RS - Serbia 3
TT - Trinidad e Tobago 3
Totale 34.464
Salva come PNG Salva come JPEG
Città #
Southend 3.560
Singapore 1.780
Ann Arbor 1.217
Milan 776
Hong Kong 734
Ashburn 705
Beijing 682
Seattle 656
San Jose 593
Chandler 585
Princeton 535
Santa Clara 453
Mountain View 414
Wilmington 396
Dallas 355
Dublin 354
Jacksonville 352
Council Bluffs 312
Redmond 299
Nanjing 242
Bengaluru 226
Los Angeles 214
Rome 203
Lauterbourg 199
Sakarya 194
Somerville 169
Boardman 168
Des Moines 150
Buffalo 143
Ho Chi Minh City 133
New York 133
Moscow 131
Serra 129
Andover 127
Kent 127
Bogotá 125
Dearborn 121
Medford 113
Shanghai 109
Guangzhou 106
Helsinki 99
Hanoi 98
Athens 93
Hefei 89
Eitensheim 87
Grafing 85
Phoenix 78
Woodbridge 78
Tokyo 77
Nanchang 70
Cangzhou 69
Tianjin 68
Warsaw 63
Jinan 62
Frankfurt am Main 61
Shenyang 61
São Paulo 56
Fairfield 52
Redwood City 51
Hamburg 48
Fuzhou 47
Houston 46
Changsha 43
Hangzhou 43
Shenzhen 43
Bologna 41
Seoul 41
Turin 40
Florence 38
Hebei 38
The Dalles 38
Toronto 38
Berlin 36
Brussels 34
Chengdu 34
Tampa 34
Cambridge 32
Naples 32
Zhengzhou 32
Verona 31
Jiaxing 30
Arezzo 29
Kunming 29
Chicago 28
Auburn Hills 27
Columbus 26
Naperville 26
Palermo 26
Munich 24
Bari 23
Genoa 23
Istanbul 23
Nuremberg 23
Catania 22
Lanzhou 22
Atlanta 21
San Diego 21
Padova 20
Da Nang 19
Haiphong 19
Totale 20.707
Salva come PNG Salva come JPEG
Nome #
Radionuclidi emettitori beta utilizzati in radioterapia metabolica : studio della purezza radionuclidica di radiofarmaci marcati con lutezio-177 1.987
Lu-177g produced with high specific activity by deuteron irradiation for metabolic radiotherapy 437
The use of liquid scintillation counting as a very sensitive radioanalytical tool for the determination of alpha, beta and electron emitting impurities in radiopharmaceutical compounds 390
Production of high specific activity NCA Lu-177g by cyclotron irradiation 380
Analisi cromatografica di radiofarmaco marcato con beta emettitore (186g-Re) utilizzato per la terapia palliativa del dolore da metastasi ossee e sua biodistribuzione 373
Analytical and radioanalytical quality control of purity and stability of radiopharmaceutical compound Re-186 HEDP for bone metastases pain palliation. 311
Determinazione della purezza radionuclidica di [153Sm]Sm-EDTP(QuadrametTM), d’impiego nella terapia palliativa del dolore da metastasi ossee 308
La trasmutazione delle scorie nucleari per la chiusura del ciclo dell’energia nucleare 288
Accurate determination of half life and radionuclidic purity of reactor produced 177gLu(177mLu) for metabolic radiotherapy 287
Accelerator and nuclear reactor production, radiochemical processing and quality control of high specific activity radionuclides for applications in the life sciences 276
Radiochemical separation and quality control of high specific activity Re-186g in no-carrier-added form from cyclotron irradiated W and W-186 targets 268
Accurate determination of radionuclidic purity and half-life of reactor produced Lu-177G for metabolic radioimmunotherapy 268
Alpha cyclotron production studies of the alpha emitter 211At/211gPo for high-LET metabolic radiotherapy 259
I sessantanni della Radiochimica e della Chimica Nucleare in UNIMI: dalle origini ai giorni nostri 257
Conceptual design of a high-brightness linac for soft X-ray SASE-FEL source 255
Deuteron cyclotron production studies of high specific activity Lu-177g in NCA form for metabolic radiotherapy 253
A cyclotron isotope center for biomedical research 252
Analytical and radioanalytical quality control in high specific activity radiotracer preparation 233
Nonlinear modelling of data in photomineralization kinetics of organic micropollutants by photocatalytic membranes immobilizing titanium dioxide in membrane reactors 229
A rapid improved method for gamma spectrometry determination of thallium-202 impurities, in [thallium-201]labelled radiopharmaceuticals 223
A rapid improved method for gamma- spectrometric determination of 202Tl impurities, in [201Tl]-labelled radiopharmaceuticals 220
A competitive method for simultaneous deuteron-cyclotron production of No-Carrier-Added copper-64 and gallium-67,66 for applications in PET radiodiagnostic and metabolic therapy of tumours 219
A new method for N.C.A. copper-64 production 219
Deuteron cyclotron production of high specific activity NCA Lu-117g for metabolic radiotherapy, as a competitive method to neutron activation in nuclear reactor 217
Determination of chemical purity of 177g,mLuCl3 for radioimmunotherapy, by ET-AAS and INAA 215
Irradiation of bismuth target for cyclotron production of 211At/211gPo AND 210At→210Po 212
Optimisation study of a-cyclotron production of At-211/Po-211g for high-LET metabolic radiotherapy purposes 210
Production of nuclear hydrogen Nu2 or hydricity by high temperature nuclear reactor 208
Cyclotron production of 211At/211gPo by 209Bi(alpha,2n) reaction 206
Cross-section studies on copper-64 with zinc target in the proton energy range from 141 down to 31 MeV 205
Risultati sperimentali nella produzione mediante fasci alfa di astato-211/polonio-211g 205
Improved radiochemical separation of No-Carrier-Added vanadium-48 from proton irradiated titanium target 204
Thin-target excitation functions and optimisation of NCA Cu-64 and Ga-66,Ga-67 production by deuteron induced nuclear reactions on natural zinc target, for radiometabolic therapy and for PET 200
Comparison between theoretical calculation and experimental results of excitation functions for production of relevant biomedical radionuclides 198
Copper-64 production studies with natural zinc targets at deuteron energy up to 19 MeV and proton energy from 141 down to 31 MeV 196
Determination of I-125 impurities in [I-123]labelled radiopharmaceuticals, by liquid scintillation counting: sensitivity of the method 194
Thin-target excitation functions and optimization of simultaneous production of NCA copper-64 and gallium-66,67 by deuteron induced nuclear reactions on a natural zinc target 194
A fast and effective method for the radiochemical separation of 211At/211gPo from cyclotron irradiated bismuth target 191
Wet-chemistry method for the separation of no-carrier-added 211At/211gPo from alpha cyclotron irradiated 209Bi target 190
Cyclotron production, radiochemical separation and quality control of platinum radiotracers for toxicological studies 190
Production of non-conventional high specific activity radionuclides for biomedical, toxicological, and environmental purposes 189
Proton and deuteron cyclotron production studies of high specific activity 186gRe for radiotherapy 189
On the high-resolution gamma-ray spectrometric measurement of 40K in natural and synthetic materials 188
Radioanalytical quality control on beta-emitting [186gRe]- and [153Sm]-radiopharmaceutical compounds for bone metastatses pain palliation 188
Production and quality control of high specific activity NCA Re-186 by cyclotron irradiation 185
A wet-chemistry method for the separation of NCA rhenium radionuclides from cyclotron irradiated tungsten target 183
Proton and deuteron cyclotron production of the beta-gamma emitter rhenium-186g for metabolic radiotherapy and spet : RENIO experiment of INFN GR-V 183
Influence of the chemical form on the plasma clearance of ruthenium in humans 181
Excitation functions and yields for Re-186g production by proton cyclotron irradiation 181
Paper radiochromatography for evaluation of radiochemical purity and stability of [186gRe]Re- HEDP in biological samples after human administration 181
Excitation functions and yields for Re-186g production by proton and deuteron cyclotron irradiation 181
Excitation functions and yields for Re-18x production by cyclotron irradiation 180
Nuclear chemistry, radiochemistry, radiation chemistry, health physics and sustainable nuclear energy production 180
Excitation functions and yields for cyclotron production of radiorhenium via deuteron irradiation : natW(d, xn)181, 182(A+B), 183, 184(m+)g, 186gRe nuclear reactions and tests on the production of 186gRe using enriched 186W 180
Influence of irradiance, flow rate, reactor geometry, and photopromoter concentration in mineralization kinetics of methane in air and in aqueous solutions by photocatalytic membranes immobilizing titanium dioxide 179
On the photon self-absorption correction for thin-target-yields vs. thick-target-yields in radionuclide production 178
Nonlinear Modelling of Data Obtained from Photocatalytic Mineralisation of 2,4-Dichlorophenol on a Titanium Dioxide Membrane 175
Cyclotron production and quality control of "high specific activity" radionuclides in "no-carrier-added" form for radioanalytical applications in the life sciences 174
How do we define the concepts specific activity, radioactive concentration, carrier, carrier-free and no-carrier-added? 171
CESIUM-137 CONTENT IN MILK - MONITORING AFTER FUKUSHIMA NUCLEAR POWER PLANT ACCIDENT 171
Thick target yield measurement of 211At through the nuclear reaction 209Bi(alpha,2n) 169
On the “artificial” nature of Tc and the “carrier-free” nature of Tc-99m from Mo-99/Tc-99m generators 168
Cyclotron production of Cu-64 by deuteron irradiation of Zn-64 168
Produzione mediante ciclotrone del radionuclide astato-211 per impiego in radioterapia metabolica ad alto LET: risultati sperimentali 168
Experimental and calculated nuclear reaction data relevant to innovative production of medical radioisotopes 167
Analytical and radioanalytical quality control of purity and stability of radiopharmaceutical [186Re]HEDP for bone metastases pain palliation 167
Stable tracer investigations in humans for assessing the biokinetics of ruthenium and zirconium radionuclides 166
Measurement of Actinides in Biological System; Radioanalytical determination of americium in human urines by extraction chromatography and high resolution alpha-spectrometry 165
Thin-target excitation functions: a powerful tool for optimising yield, specific activity and radionuclidic purity of accelerator-produced radionuclides 165
How do we ascertain specific activities in no-carrier-added radionuclide preparations? 164
Rapid determination of Sr-90 impurities in freshly generator eluted Y-90 for radiopharmaceutical preparation 161
Experimental and calculated data for innovative high specific activity medical radionuclides production 159
Radionuclidic purity and accurate half-life measurements for Lu-177g and Lu-177m 158
Accelerator and nuclear reactor production, radiochemical processing and quality control of high specific activity radionuclides for applications in the life sciences 158
Excitation functions and yields for cyclotron production of radiorhenium via (nat)W(p,xn)(181-186g)Re nuclear reactions and tests on the production of (186g)Re using enriched (186)W 154
The radiochemistry laboratory of L.A.S.A. (Segrate): Technical description and legal aspects 153
Experimental results and model calculations of excitation functions relevant to the production of specific radioisotopes for metabolic radiotherapy and for PET 152
Result on accelerator production of innovative radionuclides for metabolic radiotherapy and PET and on relevant nuclear data 151
Production study of high specific activity NCA Re-186g by proton and deuteron cyclotron irradiation 151
Produzione con Ciclotrone, Separazioni Radiochimiche e Controlli di Qualità di Radiotraccianti ad elevata Attività Specifica per studi di tossicologia ambientale 151
Production of high specific activity NCA Re-18x by cyclotron irradiation 149
Preparation of "high specific activity" radiochemical forms of vanadium, manganese and thallium for metallo-toxicological studies 148
Proposal of Mo-100(gamma,n)Mo-99 reaction study using Compton backscattering gamma-ray beams at INFN-LNF 148
Excitation functions for production of heavy residues in the interaction of carbon-12 with tantalum-181 148
NANOTOSSICOLOGIA E RICERCA: IL RUOLO DELLE TECNICHE NUCLEARI E RADIOANALITICHE 148
I sessanta anni della Radiochimica e della Chimica Nucleare in UNIMI: dalle origini ai giorni nostri 148
Photobleaching and photomineralization of azobenzene and substituted azobenzenes in aqueous solution by photocatalytic membranes immobilizing titanium dioxide 148
Update on cyclotron production studies on NCA radionuclides : copper-64, astatine-211, rhenium-186g 146
A cyclotron isotope production center for biomedical research 146
Determination of arsenic in silicon matrices by proton activation analysis 146
A new theragnostic approach in the multifunctional radionanomedicine 145
Eletto Coordinatore del Gruppo Interdivisionale di Radiochimica (GIR) della Società Chimica Italiana, SCI di Coordinamento Gruppo Interdivisionale di Radiochimica della Società Chimca Italiana 144
An absolute method for the energy calibration of cyclotron beams 144
A new alpha-emitter for nuclear medicine: U-230 142
Radionuclides and radiochemistry : part I : their role in society 142
Preparation of radionuclides and their measurement by high resolution gamma-spectrometry, beta-spectrometry and high resolution alpha-spectrometry 142
Heavy metal pollution in central Venice Lagoon bottom sediments: evaluation of the metal bioavailability by geochemical speciation procedure 142
Radiocesium contamination in soil due to the Chernobyl accident 142
Physical optimization of production by deuteron irradiation of high specific activity 177gLu suitable for radioimmunotherapy 142
Interpolation and extrapolation of gamma detection efficiency curve as a function of the distance 141
Totale 21.360
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.799
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.799
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021124 0 0 0 0 0 0 0 0 0 0 0 124
2021/20222.395 231 76 78 129 177 108 322 118 194 244 170 548
2022/20232.927 390 166 227 418 340 604 111 143 304 34 133 57
2023/20241.863 76 144 103 83 293 132 113 101 46 300 229 243
2024/20254.564 195 534 145 429 619 154 137 500 189 237 323 1.102
2025/20268.347 792 480 933 673 915 609 913 669 1.028 784 335 216
Totale 36.264